vs

Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and Ingredion Inc (INGR). Click either name above to swap in a different company.

Ingredion Inc is the larger business by last-quarter revenue ($1.8B vs $1.0B, roughly 1.7× Everus Construction Group, Inc.). Ingredion Inc runs the higher net margin — 9.5% vs 5.5%, a 4.0% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs -2.4%). Ingredion Inc produced more free cash flow last quarter ($270.0M vs $23.5M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs -3.4%).

Ingredion Inc. is an American food and beverage ingredient provider based in Westchester, Illinois, producing mainly starches, non-GMO sweeteners, stevia, and pea protein. The company turns corn, tapioca, potatoes, plant-based stevia, grains, fruits, gums and other vegetables into ingredients for the food, beverage, brewing, and pharmaceutical industries and numerous industrial sectors. It has about 12,000 employees in 44 locations, and customers in excess of 120 countries.

ECG vs INGR — Head-to-Head

Bigger by revenue
INGR
INGR
1.7× larger
INGR
$1.8B
$1.0B
ECG
Growing faster (revenue YoY)
ECG
ECG
+35.5% gap
ECG
33.2%
-2.4%
INGR
Higher net margin
INGR
INGR
4.0% more per $
INGR
9.5%
5.5%
ECG
More free cash flow
INGR
INGR
$246.5M more FCF
INGR
$270.0M
$23.5M
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
-3.4%
INGR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ECG
ECG
INGR
INGR
Revenue
$1.0B
$1.8B
Net Profit
$55.3M
$167.0M
Gross Margin
11.6%
24.5%
Operating Margin
6.8%
12.5%
Net Margin
5.5%
9.5%
Revenue YoY
33.2%
-2.4%
Net Profit YoY
60.4%
72.2%
EPS (diluted)
$1.09
$2.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECG
ECG
INGR
INGR
Q4 25
$1.0B
$1.8B
Q3 25
$986.8M
$1.8B
Q2 25
$921.5M
$1.8B
Q1 25
$826.6M
$1.8B
Q4 24
$759.6M
$1.8B
Q3 24
$761.0M
$1.9B
Q2 24
$703.4M
$1.9B
Q1 24
$625.7M
$1.9B
Net Profit
ECG
ECG
INGR
INGR
Q4 25
$55.3M
$167.0M
Q3 25
$57.0M
$171.0M
Q2 25
$52.8M
$196.0M
Q1 25
$36.7M
$197.0M
Q4 24
$34.5M
$97.0M
Q3 24
$41.8M
$188.0M
Q2 24
$39.0M
$148.0M
Q1 24
$28.2M
$216.0M
Gross Margin
ECG
ECG
INGR
INGR
Q4 25
11.6%
24.5%
Q3 25
12.6%
25.1%
Q2 25
13.0%
26.0%
Q1 25
11.2%
25.7%
Q4 24
11.4%
24.9%
Q3 24
11.8%
25.6%
Q2 24
12.6%
23.7%
Q1 24
11.9%
22.2%
Operating Margin
ECG
ECG
INGR
INGR
Q4 25
6.8%
12.5%
Q3 25
7.3%
13.7%
Q2 25
7.9%
14.8%
Q1 25
6.2%
15.2%
Q4 24
6.1%
9.0%
Q3 24
7.1%
14.3%
Q2 24
7.3%
12.8%
Q1 24
6.2%
11.3%
Net Margin
ECG
ECG
INGR
INGR
Q4 25
5.5%
9.5%
Q3 25
5.8%
9.4%
Q2 25
5.7%
10.7%
Q1 25
4.4%
10.9%
Q4 24
4.5%
5.4%
Q3 24
5.5%
10.1%
Q2 24
5.5%
7.9%
Q1 24
4.5%
11.5%
EPS (diluted)
ECG
ECG
INGR
INGR
Q4 25
$1.09
$2.58
Q3 25
$1.11
$2.61
Q2 25
$1.03
$2.99
Q1 25
$0.72
$3.00
Q4 24
$0.68
$1.43
Q3 24
$0.82
$2.83
Q2 24
$0.76
$2.22
Q1 24
$0.55
$3.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECG
ECG
INGR
INGR
Cash + ST InvestmentsLiquidity on hand
$1.0B
Total DebtLower is stronger
$281.5M
Stockholders' EquityBook value
$629.8M
$4.3B
Total Assets
$1.7B
$7.9B
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECG
ECG
INGR
INGR
Q4 25
$1.0B
Q3 25
$915.0M
Q2 25
$861.0M
Q1 25
$837.0M
Q4 24
$997.0M
Q3 24
$553.0K
$877.0M
Q2 24
$505.0M
Q1 24
$438.0M
Total Debt
ECG
ECG
INGR
INGR
Q4 25
$281.5M
Q3 25
$285.1M
Q2 25
$288.6M
Q1 25
$292.1M
Q4 24
$295.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ECG
ECG
INGR
INGR
Q4 25
$629.8M
$4.3B
Q3 25
$573.0M
$4.2B
Q2 25
$514.4M
$4.2B
Q1 25
$460.2M
$4.0B
Q4 24
$422.6M
$3.8B
Q3 24
$453.3M
$4.0B
Q2 24
$490.0M
$3.7B
Q1 24
$464.3M
$3.7B
Total Assets
ECG
ECG
INGR
INGR
Q4 25
$1.7B
$7.9B
Q3 25
$1.6B
$7.8B
Q2 25
$1.5B
$7.8B
Q1 25
$1.4B
$7.5B
Q4 24
$1.3B
$7.4B
Q3 24
$1.3B
$7.5B
Q2 24
$7.2B
Q1 24
$7.3B
Debt / Equity
ECG
ECG
INGR
INGR
Q4 25
0.45×
Q3 25
0.50×
Q2 25
0.56×
Q1 25
0.63×
Q4 24
0.70×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECG
ECG
INGR
INGR
Operating Cash FlowLast quarter
$48.2M
$405.0M
Free Cash FlowOCF − Capex
$23.5M
$270.0M
FCF MarginFCF / Revenue
2.3%
15.4%
Capex IntensityCapex / Revenue
2.4%
7.7%
Cash ConversionOCF / Net Profit
0.87×
2.43×
TTM Free Cash FlowTrailing 4 quarters
$90.0M
$511.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECG
ECG
INGR
INGR
Q4 25
$48.2M
$405.0M
Q3 25
$76.2M
$277.0M
Q2 25
$25.3M
$185.0M
Q1 25
$7.1M
$77.0M
Q4 24
$436.0M
Q3 24
$78.9M
$479.0M
Q2 24
$312.0M
Q1 24
$21.9M
$209.0M
Free Cash Flow
ECG
ECG
INGR
INGR
Q4 25
$23.5M
$270.0M
Q3 25
$65.7M
$172.0M
Q2 25
$12.3M
$84.0M
Q1 25
$-11.4M
$-15.0M
Q4 24
$311.0M
Q3 24
$60.9M
$429.0M
Q2 24
$257.0M
Q1 24
$12.6M
$144.0M
FCF Margin
ECG
ECG
INGR
INGR
Q4 25
2.3%
15.4%
Q3 25
6.7%
9.5%
Q2 25
1.3%
4.6%
Q1 25
-1.4%
-0.8%
Q4 24
17.3%
Q3 24
8.0%
22.9%
Q2 24
13.7%
Q1 24
2.0%
7.7%
Capex Intensity
ECG
ECG
INGR
INGR
Q4 25
2.4%
7.7%
Q3 25
1.1%
5.8%
Q2 25
1.4%
5.5%
Q1 25
2.2%
5.1%
Q4 24
6.9%
Q3 24
2.4%
2.7%
Q2 24
2.9%
Q1 24
1.5%
3.5%
Cash Conversion
ECG
ECG
INGR
INGR
Q4 25
0.87×
2.43×
Q3 25
1.34×
1.62×
Q2 25
0.48×
0.94×
Q1 25
0.19×
0.39×
Q4 24
4.49×
Q3 24
1.89×
2.55×
Q2 24
2.11×
Q1 24
0.77×
0.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

INGR
INGR

Food And Industrial Ingredients LATAM Segment$599.0M34%
Texture And Healthful Solutions Segment$598.0M34%
Food And Industrial Ingredients U.S.Canada Segment$486.0M28%
Other$74.0M4%

Related Comparisons